HHResearcher profile · from public sources
Hayato Hikita
Targets
Filled chips are declared by the researcher; the others come from publications (number of works).
Now
Trials, publications and grants since Nov 2024.
Publication
Serum Agalactosyl IgG Predicts Hepatocellular Carcinoma and All-Cause Mortality After SVR in Advanced Chronic Hepatitis C.
Hepatology research : the official journal of the Japan Society of Hepatology, Aug 2026
Publication
Proteomic Analysis of Serum Extracellular Vesicles Revealed Fibulin-3 as a Novel Predictive Biomarker for Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
Hepatology research : the official journal of the Japan Society of Hepatology, Jul 2026
Publication
Evidence-Based Clinical Practice Guidelines for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 2026.
Hepatology research : the official journal of the Japan Society of Hepatology, May 2026
Publication
Comparison of outcomes of second-line durvalumab plus tremelimumab versus lenvatinib following first-line atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.
PloS one, May 2026
Publication
On-treatment viral factors affect subsequent hepatitis B surface antigen seroclearance in patients treated with nucleos(t)ide analogs for > 10 years.
Journal of gastroenterology, Apr 2026
Publication
Impact of Treatment Response to Anticoagulant Therapy on Liver-Related Events in Patients With Cirrhosis and Portal Vein Thrombosis.
Hepatology research : the official journal of the Japan Society of Hepatology, Mar 2026
Publication
Post-to Pretreatment Ratio of Serum CXCL10 Level Predicts Short-Term Liver Function Outcome in Compensated and Decompensated Cirrhotic Patients Due to Chronic Hepatitis C Virus Infection After Direct-Acting Antiviral Therapy.
Hepatology research : the official journal of the Japan Society of Hepatology, Feb 2026
Publication
Retreatment of Direct Acting Agents (DAAs) After Initial DAA Failure in Hepatitis C Patients.
Hepatology research : the official journal of the Japan Society of Hepatology, Jan 2026
Publication
Auranofin, identified by FDA-approved drug library screening, inhibits HBs antigen secretion via lysosomal damage.
PloS one, Jan 2026
Publication
NRF2-COX2-PGE 2 axis drives immune cold tumors and predicts resistance to combination immunotherapy in hepatocellular carcinoma.
Hepatology (Baltimore, Md.), Jan 2026
Publication
Growth differentiation factor 15: from stress response to clinical utility in chronic liver diseases.
Journal of gastroenterology, Dec 2025
Publication
Comparative analysis of lenvatinib use after atezolizumab plus bevacizumab versus lenvatinib as first-line therapy in unresectable hepatocellular carcinoma.
Journal of gastroenterology, Oct 2025
Co-authors
Who links you
Enter another researcher's profile link or ID to see who has published with both of you.
You have published with Susumu Eguchi directly.
Is this you? Request a correction or removal: support@frontlightresearch.com
Report an error